Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pazoo, Inc. (PZOO) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +99.1%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +99.1%, free cash flow +2.5% with operating margin 0.0% and ROIC 26.9%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PZOO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PZOO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PZOO Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PZOO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$52.8K
-52.5% YoY
FY Net Income
-$657.7K
+88.2% YoY
Free Cash Flow
-$373.1K
+70.7% YoY
Revenue Growth
-100.0%
EPS Growth
+99.1%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|
| Revenue | 0 | 31K | 27K | 111K | 53K |
| Gross Profit | -166K | 31K | -176K | 111K | 44K |
| Operating Income | -2M | -4M | -4M | -2M | -536K |
| EBITDA | -2M | -6M | -2M | -4M | -536K |
| Net Income | -5M | -12M | -7M | -6M | -658K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|
| Cash & Equivalents | 73K | 89K | 17K | 734K | 36K |
| Total Assets | 129K | 708K | 2M | 849K | 75K |
| Total Liabilities | 11M | 9M | 5M | 4M | 242K |
| Shareholder Equity | -11M | -9M | -2M | -3M | -166K |
| Total Debt | 3M | 4M | 2M | 927K | 5K |
| Net Debt | 3M | 3M | 2M | 194K | -31K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
373K
+70.7% YoY
Capital Expenditures
0
Free Cash Flow
373K
+70.7% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
48.4%
Debt / Equity
-0.28x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.